{"edges": [{"source": "HP:0001939", "target": "HP:0020169"}, {"source": "HP:0001939", "target": "HP:0025021"}, {"source": "HP:0001939", "target": "HP:0031863"}, {"source": "HP:0001939", "target": "HP:0033331"}, {"source": "HP:0033331", "target": "HP:0033332"}, {"source": "HP:0005550", "target": "HP:0005558"}, {"source": "HP:0005550", "target": "MEFV"}, {"source": "HP:0011897", "target": "MEFV"}, {"source": "HP:0020071", "target": "HP:0031863"}, {"source": "HP:0020169", "target": "MEFV"}, {"source": "HP:0031234", "target": "HP:0031236"}, {"source": "HP:0031236", "target": "MEFV"}, {"source": "HP:0033332", "target": "MEFV"}], "nodes": [{"id": "HP:0001939", "type": "HPO", "name": "Abnormality of metabolism/homeostasis", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": 0.27840060747245027, "y": -0.5764093660794574}, {"id": "HP:0020169", "type": "HPO", "name": "Abnormal drug response", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": -0.07107128547529387, "y": -0.3175683380046596}, {"id": "HP:0025021", "type": "HPO", "name": "Abnormal erythrocyte sedimentation rate", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": 0.30138982855976343, "y": -0.9997709538980531}, {"id": "HP:0031863", "type": "HPO", "name": "Bloodstream infectious agent", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": 0.49805251512711146, "y": -0.15500879331294948}, {"id": "HP:0033331", "type": "HPO", "name": "Acute phase response", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": 0.5028026884071244, "y": -0.5225361695980044}, {"id": "HP:0033332", "type": "HPO", "name": "Elevated circulating amyloid A", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": 0.20779818340600906, "y": -0.21114246242533788}, {"id": "HP:0005550", "type": "HPO", "name": "Chronic lymphatic leukemia", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": -0.6143715912774148, "y": 0.39988398091954724}, {"id": "HP:0005558", "type": "HPO", "name": "Chronic leukemia", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": -0.9456981687499211, "y": 0.6097834409848536}, {"id": "MEFV", "type": "gene", "name": "MEFV innate immuity regulator, pyrin", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": -0.20370592684926317, "y": 0.11427272260582749}, {"id": "HP:0011897", "type": "HPO", "name": "Neutrophilia", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": -0.5547809721495239, "y": -0.028891884235511974}, {"id": "HP:0020071", "type": "HPO", "name": "Viremia", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": 0.8104381678584764, "y": 0.0726788659907198}, {"id": "HP:0031234", "type": "HPO", "name": "Neutrophilic infiltration of the skin", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": -0.0850012804077979, "y": 1.0}, {"id": "HP:0031236", "type": "HPO", "name": "Predominantly dermal neutrophilic infiltrate", "cluster": "paris.cesna.2022:6391", "cluster_id": 541, "x": -0.12425276592172023, "y": 0.6147089570530255}], "hpoParentNodes": [{"id": "HP:0000118", "level": 1, "name": "Phenotypic abnormality", "type": "HPO Parent", "cluster": "paris.cesna.2022:6391", "cluster_id": 541}, {"id": "HP:0001909", "level": 1, "name": "Leukemia", "type": "HPO Parent", "cluster": "paris.cesna.2022:6391", "cluster_id": 541}, {"id": "HP:0011991", "level": 1, "name": "Abnormal neutrophil count", "type": "HPO Parent", "cluster": "paris.cesna.2022:6391", "cluster_id": 541}, {"id": "HP:0011123", "level": 1, "name": "Inflammatory abnormality of the skin", "type": "HPO Parent", "cluster": "paris.cesna.2022:6391", "cluster_id": 541}], "hpoParentEdges": [{"target": "HP:0000118", "source": "HP:0001939"}, {"target": "HP:0011123", "source": "HP:0031234"}, {"target": "HP:0011897", "source": "HP:0011991"}, {"target": "HP:0001909", "source": "HP:0005558"}]}